GF Fund Management
MAZE icon

GF Fund Management’s Maze Therapeutics MAZE Stock Holding History

GF Fund Management’s Portfolio MAZE Stock Details MAZE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$37.2K Buy
1,370
+349
+34% +$9.7K ﹤0.01% 431
2026
Q2 		$30.5K Sell
1,021
-59
-5% -$1.55K ﹤0.01% 445
2026
Q1 		$32.2K Buy
1,080
+136
+14% +$6K ﹤0.01% 451
2025
Q4 		$39.1K Buy
+944
New +$32.4K ﹤0.01% 426

Other funds holding MAZE

Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.8B AUM 32.97% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Mass General Brigham
Mass General Brigham Somerville, Massachusetts $456M AUM 27.51% 1-Year Est. Return

GF Fund Management's MAZE Position: Q3 2026 in Review

GF Fund Management increased its Maze Therapeutics (MAZE) stake by 34% in Q3 2026, buying an estimated $9.7K and bringing the position to 1,370 shares worth $37.2K. The position accounts for ﹤0.01% of the portfolio, ranked #431.

GF Fund Management first reported a position in MAZE in Q4 2025 and has held it in 4 quarters since. The position peaked at $39.1K in Q4 2025. 73 funds tracked by Wall St. Rank hold MAZE as of Q3 2026.

  • GF Fund Management held 1,370 shares of Maze Therapeutics worth $37.2K as of Q3 2026.
  • GF Fund Management bought 349 Maze Therapeutics shares in Q3 2026, an estimated $9.7K.
  • Maze Therapeutics made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #431 holding.
  • GF Fund Management first reported a position in Maze Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • GF Fund Management's Maze Therapeutics position peaked at $39.1K in Q4 2025.
  • 73 funds tracked by Wall St. Rank held Maze Therapeutics as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.